Residual effects of intranasal methamphetamine on sleep, mood, and performance

Drug and Alcohol Dependence

Volumn 94, Issue 1-3, 2008, Pages 258-262

  Perez, Audrey Y ^a   Kirkpatrick, Matthew G ^a,b   Gunderson, Erik W ^a   Marrone, Gina ^a,c   Silver, Rae ^b,c   Foltin, Richard W ^a   Hart, Carl L ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Howard Hughes Medical Institute   (United States)

^c USA   (United States)

Author keywords

Cognitive performance; Hangover; Humans; Methamphetamine abuse; Mood; Sleep

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; COGNITION; FEMALE; HANGOVER; HUMAN; MALE; MOOD; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SLEEP; SUBSTANCE ABUSE; TASK PERFORMANCE;

ADMINISTRATION, INTRANASAL; ADRENERGIC AGENTS; ADULT; AFFECT; COGNITION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; SLEEP;

EID: 39249084988     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.10.011     Document Type: Article

References (22)

1. Angrist B. Amphetamine psychosis: clinical variations of the syndrome. In: Cho A.K., and Segal D.S. (Eds). Amphetamine and its Analogues (1994), Academic Press, San Diego 387-414
2. Baker F.C., Maloney S., and Driver H.S. A comparison of subjective estimates of sleep with objective polysomnographic data in healthy men and women. J. Psychosom. Res. 47 (1999) 335-341
3. Brauer H.L., Ambre J., and de Witt H. Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy man. J. Clin. Psychopharmacol. 16 (1996) 72-76
4. Cho A.K., Melega W.P., Kuczenski R., and Segal D.S. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39 (2001) 161-166
5. Coates T., Killen J., George J.D., Marchini J., Silverman E., and Thoresen S.C. Estimating sleep parameters: a multitrait-multimethod analysis. J. Consult Clin. Psychol. 50 (1982) 345-352
6. Haney M., Ward A.S., Comer S.D., Foltin R.W., and Fischman M.W. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology 22 (1999) 504-512
7. Hart, C.L., Gunderson, E.W., Perez, A., Kirkpatrick, M.G., Thurmond, A., Comer, S.D., Foltin, R.W., 2007. Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology (Epub ahead of print).
8. Hart C.L., Haney M., Foltin R.W., and Fischman M.W. Effects of the NMDA antagonist memantine on human methamphetamine discrimination. Psychopharmacology 164 (2002) 376-384
9. Hart C.L., van Gorp W., Haney M., Foltin F.W., and Fischman M.W. Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 25 (2001) 757-765
10. Kelly T.H., Foltin R.W., Emurian C.S., and Fischman M.W. Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam. J. Anal. Toxicol. 17 (1993) 264-272
11. Kushida C.A., Chang A., Gadkary C., Guilleminault C., Carrillo O., and Dement W.C. Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep Med. 2 (2001) 389-396
12. London E.D., Berman S.M., Voytek B., Simon S.L., Mandelkern M.A., Monterosso J., Thompson P.M., Brody A.L., Geaga J.A., Hong M.S., Hayashi K.M., Rawson R.A., and Ling W. Celebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol. Psychiatry 58 (2005) 770-778
13. London E.D., Simon S.L., Berman S.M., Mandelkern M.A., Lichtman A.M., Bramen J., Shinn A.K., Miotto K., Learn J., Dong Y., Matochik J.A., Kurian V., Newton T., Woods R., Rawson R., and Walter L. Mood disturbances and regional celebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch. Gen. Psychiatry 61 (2004) 73-84
14. Johnson B.A., Ait-Daoud N., and Wells L.T. Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on d-methamphetamine-induced cognitive and physiological changes in humans. Neuropsychopharmacology 22 (2000) 504-512
15. Johnson B.A., Roache J.D., Bordnick P.S., and Ait-Daoud N. Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study. Psychopharmacology 144 (1999) 295-300
16. McGregor C., Srisurapanont M., Jittiwutikarn J., Laobhripatr S., Wongtan T., and White J.M. The nature, time course and severity of methamphetamine withdrawal. Addiction 100 (2005) 1320-1329
17. McLeod D.R., Griffiths R.R., Bigelow G.E., and Yingling J. An automated version of the digit symbol substitution test (DSST). Behav. Res. Methods Instrum. 14 (1982) 463-466
18. Miller T.P., Taylor J.L., and Tinklenberg J.R. A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics. Neuropsychobiology 19 (1988) 90-96
19. Peck J.A., Shoptaw S., Rotheram-Fuller E., Reback C.J., and Bierman B. HIV-associated medical, behavioral, and psychiatric characteristics of treatment-seeking, methamphetamine-dependent men who have sex with men. J. Addict Dis. 24 (2005) 115-132
20. Tworoger S.S., Davis S., Vitiello M.V., Lentz M.J., and McTiernan A. Factors associated with objective (actigraphic) and subjective sleep quality in young adult women. J. Psychosom. Res. 59 (2005) 11-19
21. Vitiello M.V., Larsen L.H., and Moe K.E. Age-related sleep change: Gender and estrogen effects on the subjective-objective sleep quality relationships of healthy, noncomplaining older men and women. J. Psychosom. Res. 56 (2004) 503-510
22. Wesnes K., and Warburton D.M. Effects of smoking on rapid information processing performance. Neuropsychologybiology 9 (1983) 223-229